Published in Inorg Chem on December 25, 2006
N,N-Dimethyl-4-[(2-pyrid-yl)diazen-yl]aniline. Acta Crystallogr Sect E Struct Rep Online (2010) 1.19
Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. Adv Inorg Chem (2009) 1.01
Unusual DNA binding modes for metal anticancer complexes. Biochimie (2009) 0.95
Catalytic organometallic anticancer complexes. Proc Natl Acad Sci U S A (2008) 0.95
Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells. J Inorg Biochem (2010) 0.91
Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells. Cell Biol Toxicol (2013) 0.86
Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes. Eur J Inorg Chem (2011) 0.77
Crystal structure of [3-amino-2-(phenyl-diazenyl)-pyridine]chlorido-(η(6)-p-cymene)-ruthenium(II) chloride. Acta Crystallogr E Crystallogr Commun (2015) 0.75
Differences in the CO photolability of cis- and trans- [RuCl2(azpy)(CO)2] complexes: Effect of metal-to-ligand back-bonding. Inorganica Chim Acta (2013) 0.75
The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chem Soc Rev (2017) 0.75
A temporal constraint structure for extracting temporal information from clinical narrative. J Biomed Inform (2005) 4.42
The evaluation of a temporal reasoning system in processing clinical discharge summaries. J Am Med Inform Assoc (2007) 3.71
System architecture for temporal information extraction, representation and reasoning in clinical narrative reports. AMIA Annu Symp Proc (2005) 2.93
Modeling electronic discharge summaries as a simple temporal constraint satisfaction problem. J Am Med Inform Assoc (2004) 2.88
Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme. Proc Natl Acad Sci U S A (2005) 2.31
Inter-patient distance metrics using SNOMED CT defining relationships. J Biomed Inform (2006) 2.12
New trends for metal complexes with anticancer activity. Curr Opin Chem Biol (2008) 2.06
Structures of piperazine, piperidine and morpholine. Acta Crystallogr B (2004) 1.95
A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew Chem Int Ed Engl (2010) 1.74
A novel protein-mineral interface. Nat Struct Biol (2003) 1.69
Highly luminescent, triple- and quadruple-stranded, dinuclear Eu, Nd, and Sm(III) lanthanide complexes based on bis-diketonate ligands. J Am Chem Soc (2004) 1.53
Periodic iron nanomineralization in human serum transferrin fibrils. Angew Chem Int Ed Engl (2008) 1.52
Metal complexes as DNA intercalators. Acc Chem Res (2011) 1.47
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov Today (2009) 1.47
Effect of pressure on the crystal structure of salicylaldoxime-I, and the structure of salicylaldoxime-II at 5.93 GPa. Acta Crystallogr B (2006) 1.45
Organometallic half-sandwich iridium anticancer complexes. J Med Chem (2011) 1.40
Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity. Inorg Chem (2007) 1.40
Enhancing SMM properties in a family of [Mn6] clusters. Chem Commun (Camb) (2007) 1.39
Ligand-selective photodissociation from [Ru(bpy)(4AP)4]2+: a spectroscopic and computational study. Inorg Chem (2009) 1.35
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem Commun (Camb) (2005) 1.34
Zinc(II) complexes of constrained antiviral macrocycles. Dalton Trans (2012) 1.28
Structure and dynamics of metallomacrocycles: recognition of zinc xylyl-bicyclam by an HIV coreceptor. J Am Chem Soc (2002) 1.26
Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. J Am Chem Soc (2002) 1.26
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. Biochemistry (2003) 1.25
Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J (2004) 1.24
A potent cytotoxic photoactivated platinum complex. Proc Natl Acad Sci U S A (2007) 1.21
Exploration of the medical periodic table: towards new targets. Chem Commun (Camb) (2013) 1.18
Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms. J Am Chem Soc (2003) 1.18
Toward a magnetostructural correlation for a family of Mn6 SMMs. J Am Chem Soc (2007) 1.16
Isotopic polymorphism in pyridine. Angew Chem Int Ed Engl (2009) 1.13
Combined theoretical and computational study of interstrand DNA guanine-guanine cross-linking by trans-[Pt(pyridine)2] derived from the photoactivated prodrug trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2]. Inorg Chem (2012) 1.11
Configurationally restricted bismacrocyclic CXCR4 receptor antagonists. J Med Chem (2006) 1.10
Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents. Chem Asian J (2008) 1.10
Synthetic and structural studies of cobalt-pivalate complexes. Chemistry (2003) 1.10
Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. Dalton Trans (2009) 1.10
Multiple bacteria encode metallothioneins and SmtA-like zinc fingers. Mol Microbiol (2002) 1.09
Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Chemistry (2003) 1.09
Interdomain zinc site on human albumin. Proc Natl Acad Sci U S A (2003) 1.08
Synergistic anion and metal binding to the ferric ion-binding protein from Neisseria gonorrhoeae. J Biol Chem (2002) 1.08
Photoactivatable platinum complexes. Anticancer Agents Med Chem (2007) 1.08
A record anisotropy barrier for a single-molecule magnet. J Am Chem Soc (2007) 1.07
Cyclam complexes and their applications in medicine. Chem Soc Rev (2004) 1.07
Transport of metal salts by zwitterionic ligands; simple but highly efficient salicylaldoxime extractants. Chem Commun (Camb) (2008) 1.06
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. J Med Chem (2006) 1.06
Microwave-assisted synthesis of a hexanuclear Mn(III) single-molecule magnet. Inorg Chem (2006) 1.05
A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin. Chemistry (2006) 1.05
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers. Proc Natl Acad Sci U S A (2003) 1.04
Anti-viral cyclam macrocycles : rapid zinc uptake at physiological pH. Chem Commun (Camb) (2004) 1.03
Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans (2008) 1.02
Horseshoes, rings, and distorted rings: studies of cyclic chromium-fluoride cages. Angew Chem Int Ed Engl (2003) 1.02
Configurations of nickel-cyclam antiviral complexes and protein recognition. Chemistry (2007) 1.02
Role of Tyr84 in controlling the reactivity of Cys34 of human albumin. FEBS J (2005) 1.02
Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. Adv Inorg Chem (2009) 1.01
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J Am Chem Soc (2006) 1.01
Designing organometallic compounds for catalysis and therapy. Chem Commun (Camb) (2012) 1.00
Photoactivatable metal complexes: from theory to applications in biotechnology and medicine. Philos Trans A Math Phys Eng Sci (2013) 1.00
Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway. Chem Biol (2007) 1.00
Handling implicit and uncertain temporal information in medical text. AMIA Annu Symp Proc (2006) 1.00
Osmium(II) and ruthenium(II) arene maltolato complexes: rapid hydrolysis and nucleobase binding. Chemistry (2007) 1.00
Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity. Proc Natl Acad Sci U S A (2005) 1.00
Investigating the effect of hydrogen bonding environments in amide cleavage reactions at zinc(II) complexes with intramolecular amide oxygen co-ordination. Dalton Trans (2004) 0.99
Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. Chem Biol (2005) 0.98
An Asymmetric Enzyme-Catalyzed Retro-Claisen Reaction for the Desymmetrization of Cyclic beta-Diketones This work was supported by the BBSRC (grants to N.J.T. and S.L.F.) and the European Commission (grant to J.G.). We also thank Mr. J. Millar and Dr. D. Uhrin for assistance with NMR spectroscopy. Angew Chem Int Ed Engl (2001) 0.98
Quantifying the relative contribution of hydrogen bonding and hydrophobic environments, and coordinating groups, in the zinc(II)-water acidity by synthetic modelling chemistry. Dalton Trans (2004) 0.97
High-pressure neutron diffraction study of L-serine-I and L-serine-II, and the structure of L-serine-III at 8.1 GPa. Acta Crystallogr B (2006) 0.97
Next-generation metal anticancer complexes: multitargeting via redox modulation. Inorg Chem (2013) 0.97
The strength of hydrogen bonding to metal-bound ligands can contribute to changes in the redox behaviour of metal centres. Dalton Trans (2006) 0.97
Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands. J Med Chem (2007) 0.97
Insights into how nucleotide-binding domains power ABC transport. Structure (2009) 0.97
Unusual DNA binding modes for metal anticancer complexes. Biochimie (2009) 0.95
Catalytic organometallic anticancer complexes. Proc Natl Acad Sci U S A (2008) 0.95
Photophysics and X-ray structure of crystalline 2-aminopurine. Chemphyschem (2007) 0.95
Organoiridium complexes: anticancer agents and catalysts. Acc Chem Res (2014) 0.95